Biodesix Shares Outstanding 2020-2025 | BDSX
Biodesix shares outstanding from 2020 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Biodesix Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 130 |
| 2023 | 82 |
| 2022 | 42 |
| 2021 | 27 |
| 2020 | 5 |
| 2019 | 0 |
| Biodesix Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 147 |
| 2024-12-31 | 130 |
| 2024-09-30 | 146 |
| 2024-06-30 | 127 |
| 2024-03-31 | 97 |
| 2023-12-31 | 82 |
| 2023-09-30 | 80 |
| 2023-06-30 | 79 |
| 2023-03-31 | 78 |
| 2022-12-31 | 42 |
| 2022-09-30 | 40 |
| 2022-06-30 | 39 |
| 2022-03-31 | 31 |
| 2021-12-31 | 27 |
| 2021-09-30 | 28 |
| 2021-06-30 | 28 |
| 2021-03-31 | 27 |
| 2020-12-31 | 5 |
| 2020-09-30 | 0 |
| 2020-06-30 | 0 |
| 2020-03-31 | 0 |
| 2019-12-31 | |
| 2019-09-30 | 0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.040B | $0.071B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.538B | 26.55 |
| Elevance Health (ELV) | United States | $93.196B | 12.03 |
| CVS Health (CVS) | United States | $80.632B | 10.02 |
| Cencora (COR) | United States | $56.777B | 19.75 |
| DiDi Global (DIDIY) | China | $22.309B | 33.86 |
| Natera (NTRA) | United States | $21.101B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.924B | 13.68 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.447B | 0.00 |
| CochLear (CHEOY) | Australia | $11.597B | 0.00 |
| Revvity (RVTY) | United States | $11.030B | 18.98 |
| ICON (ICLR) | Ireland | $10.666B | 9.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Doximity (DOCS) | United States | $9.895B | 46.09 |
| Avantor (AVTR) | United States | $9.179B | 13.34 |
| Medpace Holdings (MEDP) | United States | $8.813B | 23.41 |
| HealthEquity (HQY) | United States | $8.752B | 43.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.050B | 13.81 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.153B | 24.48 |
| BrightSpring Health Services (BTSG) | United States | $4.151B | 38.42 |
| Sotera Health (SHC) | United States | $3.639B | 20.68 |
| Alignment Healthcare (ALHC) | United States | $3.102B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.973B | 38.67 |
| Concentras Parent (CON) | United States | $2.889B | 16.70 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.164B | 9.23 |
| GeneDx Holdings (WGS) | United States | $2.058B | 79.24 |
| Premier (PINC) | United States | $1.902B | 14.44 |
| Progyny (PGNY) | United States | $1.875B | 41.26 |
| PACS (PACS) | United States | $1.606B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.418B | 28.36 |
| Pediatrix Medical (MD) | United States | $1.302B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.089B | 0.00 | |
| Agilon Health (AGL) | United States | $1.027B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.988B | 15.43 |
| Nutex Health (NUTX) | United States | $0.986B | 14.90 |
| AMN Healthcare Services Inc (AMN) | United States | $0.878B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.84 |
| InnovAge Holding (INNV) | United States | $0.572B | 0.00 |
| Enhabit (EHAB) | United States | $0.537B | 44.21 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 11.67 |
| LifeMD (LFMD) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| SBC Medicals (SBC) | United States | $0.368B | 0.00 |
| Beauty Health (SKIN) | United States | $0.212B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| KindlyMD (KDLY) | United States | $0.092B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |